B. Metzler seel. Sohn & Co. AG Buys 32,949 Shares of HealthEquity, Inc. $HQY

Key Points

• B. Metzler seel. Sohn & Co. AG increased its holdings in HealthEquity, Inc. by 53% in Q1, owning 95,147 shares valued at approximately $8.4 million.
• Insider activity includes Jon Kessler, a director, selling 97,767 shares and Elimelech Rosner, EVP, selling 58,000 shares, indicating significant insider selling.
• HealthEquity has shown strong financial results, with an EPS of $0.97 for the last quarter, beating analysts' estimates, and analysts have raised their target prices for the stock significantly.

B. Metzler seel. Sohn & Co. AG grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 53.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 95,147 shares of the company's stock after buying an additional 32,949 shares during the period. B. Metzler seel. Sohn & Co. AG owned 0.11% of HealthEquity worth $8,408,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of HQY. Versant Capital Management Inc bought a new position in HealthEquity in the 1st quarter worth about $28,000. Northwestern Mutual Wealth Management Co. boosted its stake in HealthEquity by 176.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock worth $58,000 after purchasing an additional 418 shares in the last quarter. Larson Financial Group LLC boosted its stake in HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after purchasing an additional 642 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S bought a new position in HealthEquity in the 1st quarter worth about $65,000. Finally, Whipplewood Advisors LLC boosted its stake in HealthEquity by 5,060.0% in the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after purchasing an additional 759 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

Insider Activity

In other news, EVP Elimelech Rosner sold 58,000 shares of the company's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. This represents a 43.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at $5,414,579.25. The trade was a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 291,744 shares of company stock valued at $32,705,007 in the last quarter. 1.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Royal Bank Of Canada dropped their price target on shares of HealthEquity from $117.00 to $109.00 and set an "outperform" rating on the stock in a research note on Thursday. Raymond James Financial reiterated a "strong-buy" rating and issued a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft upped their price target on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. Bank of America upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. Finally, Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $117.82.

HealthEquity Stock Performance

NASDAQ:HQY traded up $1.04 during mid-day trading on Monday, reaching $89.33. The company's stock had a trading volume of 1,519,644 shares, compared to its average volume of 946,119. HealthEquity, Inc. has a 12-month low of $73.84 and a 12-month high of $116.65. The firm's fifty day moving average price is $95.50 and its two-hundred day moving average price is $95.57. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a market cap of $7.72 billion, a P/E ratio of 65.20, a PEG ratio of 1.38 and a beta of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The firm had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. During the same quarter in the prior year, the firm earned $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.